Compare TOVX & TWAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TOVX | TWAV |
|---|---|---|
| Founded | 2001 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4M | 7.2M |
| IPO Year | 2012 | N/A |
| Metric | TOVX | TWAV |
|---|---|---|
| Price | $0.19 | $0.74 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 6.0M | 114.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.16 | $0.58 |
| 52 Week High | $1.50 | $2.41 |
| Indicator | TOVX | TWAV |
|---|---|---|
| Relative Strength Index (RSI) | 46.39 | 23.35 |
| Support Level | $0.17 | N/A |
| Resistance Level | $0.27 | $2.30 |
| Average True Range (ATR) | 0.02 | 0.19 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 20.27 | 15.14 |
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.